TrialClinical colorectal cancer2014

A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers.

Crystal S Denlinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.